CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer-Reference-Cited by-同舟云学术

CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer

Published:2021-11-11 Issue: Volume: Page:
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Adachi Kai,Sakurai Yasutaka,Ichinoe Masaaki,Tadehara Masayoshi,Tamaki Akihiro,Kesen Yurika,Kato Takuya,Mii Shinji,Enomoto Atsushi,Takahashi Masahide,Koizumi Wasaburo,Murakumo Yoshiki^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-021-03230-2.pdf

Reference38 articles.

1. Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395:2008–2020

2. Neoptolemos JP, Stochen DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

3. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691–1703

4. Lin M, Sutherland DR, Horsfall W, Totty N, Yeo E, Nayar R et al (2002) Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins. Blood 99:1683–1691

5. Solomon KR, Sharma P, Chan M, Morrison PT, Finberg RW (2004) CD109 represents a novel branch of the α2-macroglobulin/complement gene family. Gene 327:171–183

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling;Pathology - Research and Practice;2023-05